Furthermore, we found that chemerin levels were significantly higher in the plasma of CRC patients than in healthy donors (Fig. 7d), suggesting that chemerin may serve as a predictive marker for CRC. This evidence concerns the gene RARRES2 and colorectal carcinoma.